BNB Plus Corp., formerly Applied DNA Sciences, Inc., is a digital asset treasury (DAT) company that has adopted BNB, the native cryptocurrency of the Binance blockchain ecosystem, as its primary reserve asset. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Company Information
About this company
Key people
Joshua Kruger
Chairman of the Board
Clay Shorrock
President, Chief Executive Officer
Beth M. Jantzen
Chief Financial Officer
Patrick Horsman
Chief Investment Officer
Judith Murrah
Director
Robert B. Catell
Independent Director
Joseph D. Ceccoli
Independent Director
James G. B. Haft
Independent Director
Yacov A. Shamash
Independent Director
Click to see more
Key facts
- Shares in issue5.45m
- EPICBNBX
- ISINUS03815U6073
- LocationUnited States
- SectorBasic Materials
- IndustryChemical Manufacturing
- Market cap$4.08m
- Employees26
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.